Gene · 27329
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antibody-Based Therapeutics for Hypercholesterolemia. | Biologics | 2025 | 41179333 | PubTator, text mining | PubMed |
| Clustered Regularly Interspaced Short Palindromic Repeats Genome Editing for Cardiovascular Disease: The Future Is Here. | Cardiol Rev | 2025 | 41166658 | PubTator, text mining | PubMed |
| Severe Familial Hypertriglyceridemia in a Child with Compound Heterozygous Pathogenic APOA5 Variants: A Case Report and Therapeutic Challenge. | J Clin Res Pediatr Endocrinol | 2025 | 41165100 | PubTator, text mining | PubMed |
| Angiopoietin-like 3 monomers are abundant in human plasma but are unable to inhibit endothelial lipase. | JCI Insight | 2025 | 41148215 | PubTator, text mining | PubMed |
| Pediatric Hypertriglyceridemia: Lipoprotein Metabolism, Etiology, and Management. | Curr Pediatr Rep | 2025 | 41103488 | PubTator, text mining | PubMed |
| The endocrine role of hepatokines: implications for human health and disease. | Front Endocrinol (Lausanne) | 2025 | 41089288 | PubTator, text mining | PubMed |
| Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets. | Mol Biomed | 2025 | 41062796 | PubTator, text mining | PubMed |
| Emerging ANGPTL3-directed therapies for hyperlipidemia: insights from two recent phase II trials. | Expert Opin Investig Drugs | 2025 | 41044048 | PubTator, text mining | PubMed |
| Novel therapies for lowering low-density lipoprotein levels for atherosclerotic cardiovascular disease prevention: reaching the target where others have failed. | Expert Rev Cardiovasc Ther | 2025 | 41039724 | PubTator, text mining | PubMed |
| Emerging Triglyceride-Rich Lipoprotein Targeted Therapies: An Unmet Need in Cardiometabolic Disease. | Pharmaceutics | 2025 | 41012446 | PubTator, text mining | PubMed |
| Insights into Causal Associations of Lipid Traits and Lipid-modifying Drug Targets with Uric Acid and Risk of Gout. | Phenomics | 2025 | 41001433 | PubTator, text mining | PubMed |
| Circulating Angiopoietin-Like Protein 3 Level and Plaque Calcification: An Optical Coherence Tomography Imaging Analysis. | CJC Open | 2025 | 41001257 | PubTator, text mining | PubMed |
| PCSK9: Its Role in Lipid Metabolism and as a Novel Target for the Treatment of Metabolic Kidney Disease. | Curr Vasc Pharmacol | 2025 | 40993930 | PubTator, text mining | PubMed |
| Assessing long-term pleiotropic effects of potential novel triglyceride-lowering medications using variants identified by Mendelian randomization. | medRxiv | 2025 | 40963757 | PubTator, text mining | PubMed |
| Discovery, Optimization, and Evaluation of Novel ANGPTL3 Modulators for the Treatment of Hyperlipidemia. | J Med Chem | 2025 | 40956249 | PubTator, text mining | PubMed |
| Genetic association of lipids characteristics and lipid lowering drug target genes with sepsis. | PLoS One | 2025 | 40934270 | PubTator, text mining | PubMed |
| Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIV. | J Clin Invest | 2025 | 40924496 | PubTator, text mining | PubMed |
| The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications. | Eur Heart J | 2025 | 40911366 | PubTator, text mining | PubMed |
| The Causal Mechanism Between the Dipeptidyl Peptidase-4, Heart Failure, and Other Cardiovascular Diseases: A Mendelian Randomization and Mediation Study. | Int J Endocrinol | 2025 | 40904650 | PubTator, text mining | PubMed |
| Beyond High-density Lipoprotein-cholesterol: Unraveling the Complexity of High-density Lipoprotein Functionality. | J Atheroscler Thromb | 2025 | 40903276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27329/papers?page=9